Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial

Abstract

Treatment of A. lumbricoides with albendazole in HIV-1-coinfected adults resulted in significantly increased CD4 cell counts during 3-month follow-up. Given the high prevalence of A. lumbricoides infection worldwide, deworming may be an important potential strategy to delay HIV-1 progression.